Abstract
Parthenolide (PTL) is a natural product from the shoots of Tanacetum parthenium, which has immunomodulatory effects in multiply type of diseases. This study aimed to explore the effect and the underlying mechanism of PTL on the anti-apoptotic and anti- inflammatory ability of tweak-induced podocytes. Conditionally immortalized mouse podocytes were incubated with Tumor necrosis factor-like weak inducer of apoptosis (Tweak, 100 ng/ml), PTL(10 µM) or Tweak + PTL for 12 h, 24 and 48 h, respectively. Podocytes viability was detected by CCK-8 assay. Tweak and Cxcl16 expression were evaluated by western blot and immunofluorescence assay. Dil-oxLDL stain was detected by immunofluorescence analysis. Intracellular Total Cholesterol (TC) content was measured through TC detection Kit. These results demonstrated that the podocytes cells viability was gradually decreased after treatment with different concentrations of Tweak (0, 50, 100, 150). Tweak and Cxcl16 protein expression in mouse podocytes treated with tweak were remarkably elevated and were found to have higher intracellular lipid accumulation compared with the control group, whereas co-administration with PTL, tweak and Cxcl16 expression as well as the intracellular lipid accumulation were notablely decreased in tweak-induced podocytes. Therefore, our conclusion was that tweak and Cxcl16 were involved in the regulation of tweak-induced podocytes injury. Meanwhile, the anti-apoptotic and anti-inflammatory effect of PTL may be correlated with the tweak and Cxcl16 expression decreased.
Similar content being viewed by others
References
Bukosza EN, Kornauth C, Hummel K, Schachner H, Huttary N, Krieger S, Nöbauer K, Oszwald A, Razzazi Fazeli E, Kratochwill K, Aufricht C, Szénási G, Hamar P, Gebeshuber CA (2020) ECM characterization reveals a massive activation of acute phase response during FSGS. Int J Mol Sci 21(6):2095
Rinschen MM, Huesgen PF, Koch RE (2018) The podocyte protease web: uncovering the gatekeepers of glomerular disease. Am J Physiol Renal Physiol 315(6):F1812–F1816
Che G, Gao H, Hu Q, Xie H, Zhang Y (2020) Angiotensin II promotes podocyte injury by activating Arf6-Erk1/2-Nox4 signaling pathway. PLoS ONE 15(3):e0229747
Barisoni L, Mundel P (2003) Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 23:353–360
Fuseya S, Suzuki R, Okada R, Hagiwara K, Sato T, Narimatsu H, Yokoi H, Kasahara M, Usui T, Morito N, Yamagata K, Kudo T, Takahashi S (2020) Mice lacking core 1-derived O-glycan in podocytes develop transient proteinuria, resulting in focal segmental glomerulosclerosis. Biochem Biophys Res Commun 523(4):1007–1013
Cybulsky AV (2011) Membranous nephropathy. Contrib Nephrol 169:107–125
Xu L, Yang HC, Hao CM, Lin ST, Gu Y, Ma J (2010) Podocyte number predicts progression of proteinuria in IgA nephropathy. Mod Pathol 23:1241–1250
Keisuke S, Kohei M, Takuji E, Tomoki M, Yuichi M, Rina O, Tsukasa T, Mitsuru O (2020) Role of cathepsin L in idiopathic nephrotic syndrome in children. Med Hypotheses 141:109718
Bollain-Y-Goytia JJ, Gonza´lez-Castaneda M, Torres-Del-Muro F, Daza-Benitez L, Zapata-Benavides P et al (2011) Indian J Nephrol 21:166–171
Cambruzzi E, Pêgas KL (2019) Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: a review. J Bras Nefrol 41(3):393–399
Cassis P, Zoja C, Perico L, Remuzzi G (2019) A preclinical overview of emerging therapeutic targets for glomerular diseases. Expert Opin Ther Targets 23(7):593–606
Justo P, Sanz AB, Sanchez-Niño MD, Winkles JA, Lorz C, Egido J, Ortiz A (2006) Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 70:1750–1758
Chung AC, Lan HY (2011) Chemokines in renal injury. J Am Soc Nephrol 22:802–809
Ludwig A, Weber C (2007) Transmembrane chemokines: versatile ‘special agents’ in vascular inflammation. Thromb Haemost 97:694–703
Koziolek MJ, Vasko R, Bramlage C, Müller GA, Strutz F (2009) The CX(3) C-chemokine fractalkine in kidney diseases. Mini Rev Med Chem 9:1215–1228
Wang L, Yao X, Li Q, Sun S (2018) Effect of simvastatin on lipid accumulation and the expression of CXCL16 and nephrin in podocyte induced by oxidized LDL. J Invest Surg 31(2):69–74
Luo R, Yang Y, Cheng YC, Chang D, Liu TT, Li YQ, Dai W, Zuo MY, Xu YL, Zhang CX, Ge SW, Xu G (2020) Plasma chemokine CXC motif-ligand 16 as a predictor of renal prognosis in immunoglobulin A nephropathy. Ann Transl Med 8(6):381
He D, Hu J, Yang R, Zeng B, Yang D, Li D, Zhang M, Yang M, Ni Q, Ning R, Fan X, Li X, Mao X, Li Y (2020) Evolutionary analysis of chemokine CXCL16 and its receptor CXCR6 in murine rodents. Dev Comp Immunol 109:103718
Hu ZB, Ma KL, Zhang Y, Wang GH, Liu L, Lu J, Chen PP, Lu CC, Liu BC (2018) Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy. Acta Pharmacol Sin 39(6):1022–1033
Liang H, Liao M, Zhao W, Zheng X, Xu F, Wang H, Huang J (2018) CXCL16/ ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia- reperfusion. Biomed Pharmacother 98:347–356
Ruiz-Ortega M, Ortiz A, Ramos AM (2014) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease. Curr Opin Nephrol Hypertens 23(1):93–100
Yue Q, Gao G, Zou G, Yu H, Zheng X (2017) Natural products as adjunctive treatment for pancreatic cancer: recent trends and advancements. Biomed Res Int 2017:8412508
Sun J, Zhang C, Bao YL, Wu Y, Chen ZL, Yu CL, Huang YX, Sun Y, Zheng LH, Wang X, Li YX (2014) Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells. Asian Pac J Cancer Prev 15:4897–4902
Uchibori R, Tsukahara T, Ohmine K, Ozawa K (2014) Cancer gene therapy using mesenchymal stem cells. Int J Hematol 99:377–382
Peng S, Hu C, Liu X, Lei L, He G, Xiong C, Wu W (2020) Rhoifolin regulates oxidative stress and proinflammatory cytokine levels in Freund’s adjuvant-induced rheumatoid arthritis via inhibition of NF-κB. Braz J Med Biol Res. https://doi.org/10.1590/1414-431x20209489
Diamanti P, Cox CV, Moppett JP, Blair A (2013) Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia. Blood 121:1384–1393
Al Fatlawi AA, Al-Fatlawi AA, Irshad M, Rahisuddin, Ahmad A (2015) Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines. Pharm Biol 53:104–109
Sang WK, Park ES, Lee CS (2013) Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion. Mol Cell Biochem 385:133–144
Ren Y, Li Y, Lv J, Guo X, Zhang J, Zhou D, Zhang Z, Xue Z, Yang G, Xi Q, Liu H, Liu Z, Zhang L, Zhang Q, Yao Z, Zhang R, Da Y (2019) Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts. J Cell Biochem 120(9):15695–15708
Hao QF, Wang BB, Zhang W, Qiu W, Liu QL, Li XM (2020) NF-κB inhibitor parthenolide promotes renal tubules albumin uptake in type 2 diabetic nephropathy. Chin Med Sci J 35(1):31–42
Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, Olbricht CJ, Walli AK, Gröne HJ (2000) Oxidant stress in hyperlipi-demia-induced renal damage. Am J Physiol Renal Physiol 278:F63–F74
Singh S, Wu T, Xie C, Vanarsa K, Han J, Mahajan T, Oei HB, Ahn C, Zhou XJ, Putterman C, Saxena R, Mohan C (2012) Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther 14(4):R164
Izquierdo MC, Sanz AB, Mezzano S, Blanco J, Carrasco S, Sanchez-Niño MD, Benito-Martín A, Ruiz-Ortega M, Egido J, Ortiz A (2012) TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. Kidney Int 81(11):1098–107
Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, Wu J, Luo C, Gong W, Yin B, Xiao J, Zhou W, Peng F, Long H (2020) Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway. Int Immunopharmacol 78:106064
Valiño-Rivas L, Cuarental L, Grana O, Bucala R, Leng L, Sanz A, Gomez G, Ortiz A, Sanchez-Niño MD (2018) TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells. PLoS ONE 13(6):e0199391
Sanz AB, Sanchez-Niño MD, Ortiz A (2011) TWEAK, a multi- functional cytokine in kidney injury. Kidney Int 80:708–718
Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suarez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB (2011) The inflammatory cytokines TWEAK and TNF-αreduce renal klotho expression through NF-κB. J Am Soc Nephrol 22:1315–1325
Sanz AB, Izquierdo MC, Sanchez-Niño MD, Ucero AC, Egido J, Ruiz-Ortega M, Ramos AM, Putterman C, Ortiz A (2014) TWEAK and the progression of renal disease: clinical translation. Nephrol Dial Transplant 29(Suppl 1):i54–i62
Ruiz-Andres O, Suarez-Alvarez B, Sa´nchez-Ramos C, Monsalve M, Sanchez- Niño MD, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB (2016) The inflammatory cytokine TWEAK decreases PGC-1αexpression and mitochondrial function in acute kidney injury. Kidney Int 89:399–410
Xia Y, Herlitz LC, Gindea S, Wen J, Pawar RD, Misharin A, Perlman H, Wu L, Wu P, Michaelson JS, Burkly LC, Putterman C (2015) Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J Am Soc Nephrol 26:1053–1070
Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, Banas B, Saleem MA, Mathieson PW, Berman JW, Michaelson JS, Putterman C (2009) TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 46:24–35
Chang TT, Chen JW (2020) The role of chemokines and chemokine receptors in diabetic nephropathy. Int J Mol Sci 21(9):E3172
Wang D, Chen X, Fu M, Xu H, Li Z (2019) Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression. Int J Mol Med 44(6):2181–2188
Anders HJ, Vielhauer V, Schlondorff D (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401–415
Sugiyama M, Kinoshita K, Funauchi M (2015) The pathogenic role of macrophage in lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi 38(3):135
Perez DL, Maier H, Nieto E, Vielhauer E, Luckow V, Mampaso B, Schlondorff F (2001) Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12:1369–1382
Acknowledgements
This work is funded by the Natural Science Foundation of Shandong Province (ZR2015HM009) and Shandong Key R&D Program (2017 GSF218005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, L., Zhang, C., Chen, Y. et al. Parthenolide ameliorates tweak-induced podocytes injury. Mol Biol Rep 47, 5165–5173 (2020). https://doi.org/10.1007/s11033-020-05591-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05591-4